Who are OLIVE OIL's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): SOYBEAN OIL, SMOFlipid (baseline), Lipofundin MCT, Lipofundin N 20%, Lipofundin MCT 20%, SMOFlipid.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/olive-oil.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

OLIVE OIL — Competitive Intelligence Brief

OLIVE OIL (OLIVE OIL) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Lipid Emulsion [EPC].

marketed Lipid Emulsion [EPC] Live · refreshed every 30 min

Target snapshot

OLIVE OIL (OLIVE OIL).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
OLIVE OIL TARGET	OLIVE OIL		marketed	Lipid Emulsion [EPC]	2013-01-01
SOYBEAN OIL	SOYBEAN OIL		marketed	Lipid Emulsion [EPC]	1982-01-01
SMOFlipid (baseline)	SMOFlipid (baseline)	General University Hospital, Prague	marketed	Lipid emulsion for parenteral nutrition
Lipofundin MCT	Lipofundin MCT	B. Braun Melsungen AG	marketed	Lipid emulsion for parenteral nutrition
Lipofundin N 20%	Lipofundin N 20%	B. Braun Melsungen AG	marketed	Lipid emulsion; parenteral nutrition component
Lipofundin MCT 20%	Lipofundin MCT 20%	B. Braun Melsungen AG	marketed	Lipid emulsion; parenteral nutrition supplement
SMOFlipid	SMOFlipid	Baylor College of Medicine	marketed	Lipid Emulsion [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Lipid Emulsion [EPC] class)

· 2 drugs in this class
Baylor College of Medicine · 1 drug in this class
Indonesia University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). OLIVE OIL — Competitive Intelligence Brief. https://druglandscape.com/ci/olive-oil. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab